These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

243 related articles for article (PubMed ID: 30148444)

  • 21. Changes in body mass index in children with juvenile idiopathic arthritis treated with tumor necrosis factor inhibitors.
    Shafferman A; Fontaine KR; Cron RQ; Beukelman T
    J Rheumatol; 2014 Jan; 41(1):113-8. PubMed ID: 24293573
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Biotherapy in juvenile idiopathic arthritis Moroccan patients: a single-center experience.
    Bouayed K; Hamraoui D; Mikou N; Sakhi A; Hilmi W
    Pan Afr Med J; 2022; 41():135. PubMed ID: 35519160
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Growth During Tocilizumab Therapy for Polyarticular-course Juvenile Idiopathic Arthritis: 2-year Data from a Phase III Clinical Trial.
    Bharucha KN; Brunner HI; Calvo Penadés I; Nikishina I; Rubio-Pérez N; Oliveira S; Kobusinska K; Schmeling H; Sztajnbok F; Weller-Heinemann F; Zholobova E; Zulian F; Allen R; Chaitow J; Frane J; Wells C; Ruperto N; De Benedetti F;
    J Rheumatol; 2018 Aug; 45(8):1173-1179. PubMed ID: 29961686
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Biologic treatment response among adults with juvenile idiopathic arthritis: results from the British Society for Rheumatology Biologics Register.
    McErlane F; Foster HE; Davies R; Lunt M; Watson KD; Symmons DP; Hyrich KL
    Rheumatology (Oxford); 2013 Oct; 52(10):1905-13. PubMed ID: 23873820
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The frequency of infections in patients with juvenile idiopathic arthritis on biologic agents: 1-year prospective study.
    Aygun D; Sahin S; Adrovic A; Barut K; Cokugras H; Camcıoglu Y; Kasapcopur O
    Clin Rheumatol; 2019 Apr; 38(4):1025-1030. PubMed ID: 30448935
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Enthesitis-related arthritis is the most common category of juvenile idiopathic arthritis in Taiwan and presents persistent active disease.
    Shih YJ; Yang YH; Lin CY; Chang CL; Chiang BL
    Pediatr Rheumatol Online J; 2019 Aug; 17(1):58. PubMed ID: 31443722
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Current therapy of polyarticular forms of juvenile idiopathic arthritis].
    Hospach A; Rühlmann JM; Weller-Heinemann F
    Z Rheumatol; 2016 Apr; 75(3):284-91. PubMed ID: 27001055
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Patient-reported Outcomes across Categories of Juvenile Idiopathic Arthritis.
    Taxter AJ; Wileyto EP; Behrens EM; Weiss PF
    J Rheumatol; 2015 Oct; 42(10):1914-21. PubMed ID: 26329337
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Risk of Serious Infections Associated with Biologic Agents in Juvenile Idiopathic Arthritis: A Systematic Review and Meta-Analyses.
    Aeschlimann FA; Chong SL; Lyons TW; Beinvogl BC; Góez-Mogollón LM; Tan S; Laxer RM
    J Pediatr; 2019 Jan; 204():162-171.e3. PubMed ID: 30318371
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Anti CD20 (Rituximab) therapy in refractory pediatric rheumatic diseases.
    Reis J; Aguiar F; Brito I
    Acta Reumatol Port; 2016; 41(1):45-55. PubMed ID: 27115107
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Transition to adult rheumatology care is necessary to maintain DMARD therapy in young people with juvenile idiopathic arthritis.
    Luque Ramos A; Hoffmann F; Albrecht K; Klotsche J; Zink A; Minden K
    Semin Arthritis Rheum; 2017 Oct; 47(2):269-275. PubMed ID: 28583690
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effect of Biologic Therapy on Clinical and Laboratory Features of Macrophage Activation Syndrome Associated With Systemic Juvenile Idiopathic Arthritis.
    Schulert GS; Minoia F; Bohnsack J; Cron RQ; Hashad S; KonÉ-Paut I; Kostik M; Lovell D; Maritsi D; Nigrovic PA; Pal P; Ravelli A; Shimizu M; Stanevicha V; Vastert S; Woerner A; de Benedetti F; Grom AA
    Arthritis Care Res (Hoboken); 2018 Mar; 70(3):409-419. PubMed ID: 28499329
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Real-world data reveals the complexity of disease modifying anti-rheumatic drug treatment patterns in juvenile idiopathic arthritis: an observational study.
    Grazziotin LR; Currie G; Twilt M; Ijzerman MJ; Kip MMA; Koffijberg H; Benseler SM; Swart JF; Vastert SJ; Wulffraat NM; Yeung RSM; Marshall DA
    Pediatr Rheumatol Online J; 2022 Apr; 20(1):25. PubMed ID: 35410419
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Biologic Switching Among Nonsystemic Juvenile Idiopathic Arthritis Patients: A Cohort Study in the Childhood Arthritis and Rheumatology Research Alliance Registry.
    Mannion ML; Xie F; Horton DB; Ringold S; Correll CK; Dennos A; Beukelman T;
    J Rheumatol; 2021 Aug; 48(8):1322-1329. PubMed ID: 32934124
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Factors associated with treatment response to etanercept in juvenile idiopathic arthritis.
    Otten MH; Prince FH; Armbrust W; ten Cate R; Hoppenreijs EP; Twilt M; Koopman-Keemink Y; Gorter SL; Dolman KM; Swart JF; van den Berg JM; Wulffraat NM; van Rossum MA; van Suijlekom-Smit LW
    JAMA; 2011 Dec; 306(21):2340-7. PubMed ID: 22056397
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Clinical remission and subsequent relapse in patients with juvenile idiopathic arthritis: predictive factors according to therapeutic approach.
    Castillo-Vilella M; Giménez N; Tandaipan JL; Quintana S; Modesto C
    Pediatr Rheumatol Online J; 2021 Aug; 19(1):130. PubMed ID: 34419078
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Predicting Which Children with Juvenile Idiopathic Arthritis Will Not Attain Early Remission with Conventional Treatment: Results from the ReACCh-Out Cohort.
    Guzman J; Henrey A; Loughin T; Berard RA; Shiff NJ; Jurencak R; Huber AM; Oen K; Gerhold K; Feldman BM; Scuccimarri R; Houghton K; Chédeville G; Morishita K; Lang B; Dancey P; Rosenberg AM; Barsalou J; Bruns A; Watanabe Duffy K; Benseler S; Duffy CM; Tucker LB;
    J Rheumatol; 2019 Jun; 46(6):628-635. PubMed ID: 30647178
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The use of methotrexate in children with rheumatic diseases.
    Gutiérrez-Suárez R; Burgos-Vargas R
    Clin Exp Rheumatol; 2010; 28(5 Suppl 61):S122-7. PubMed ID: 21044445
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Subtype frequency, demographic features, treatment and outcome of Juvenile Arthritis in one Centre in Abu Dhabi in the United Arab Emirates.
    Khawaja K; Kalas R; Almasri N
    Pediatr Rheumatol Online J; 2023 Feb; 21(1):14. PubMed ID: 36750870
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Enthesitis-related arthritis is associated with higher pain intensity and poorer health status in comparison with other categories of juvenile idiopathic arthritis: the Childhood Arthritis and Rheumatology Research Alliance Registry.
    Weiss PF; Beukelman T; Schanberg LE; Kimura Y; Colbert RA;
    J Rheumatol; 2012 Dec; 39(12):2341-51. PubMed ID: 23070991
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.